[Clinical evaluation of combination therapy with cefoxitin and amikacin in complicated urinary tract infections]. 1986

S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi

The clinical efficacy of combination therapy using Cefoxitin (CFX) and Amikacin (AMK) was studied in 19 patients with complicated urinary tract infections. Patients received 2 g of CFX i.v. and 100 mg of AMK i.m. twice a day. The overall clinical efficacy of treatment was evaluated by the criteria proposed by the UTI Committee, Japan, as excellent, moderate or poor. The overall clinical efficacy was excellent in 89%, moderate in 5% and poor in 5% of the patients. Of the 21 strains isolated from the patients, 20 strains (95%) were eradicated. No subjective side effects were observed. Drug-related aggravation in laboratory tests were observed slight elevations of glutomic-oxalacefic transaminase, glutamic-pyruvic transaminase and alkaliphosphatase in 2 cases, but all of them were minimal and reversible. Underlying condition-related aggravation was observed a slight elevation of BUN and creatinine clearance in 1 case. These results suggest that the combination therapy with CFX and AMK might be useful in the treatment of complicated urinary tract infections.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
October 1987, Hinyokika kiyo. Acta urologica Japonica,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
November 1976, The Journal of infectious diseases,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
August 1983, The American journal of medicine,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
August 1983, The Japanese journal of antibiotics,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
May 1986, The Journal of antimicrobial chemotherapy,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
October 1978, Antimicrobial agents and chemotherapy,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
March 1987, The Japanese journal of antibiotics,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
September 1987, Hinyokika kiyo. Acta urologica Japonica,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
May 1983, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
S Sakashita, and Y Shinno, and Y Asano, and S Tubo, and K Imanaka, and N Miyabe, and S Nagamori, and Y Takahashi, and T Koyanagi
July 1978, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!